Does Adding Daratumumab Benefit TransplantIneligible Myeloma Patients

Does Adding Daratumumab Benefit Transplant-Ineligible Myeloma Patients?

Researchers examined adding daratumumab to standard of care in newly diagnosed transplant-ineligible myeloma patients.

Original Article: Does Adding Daratumumab Benefit Transplant-Ineligible Myeloma Patients?

More From BioPortfolio on "Does Adding Daratumumab Benefit Transplant-Ineligible Myeloma Patients?"